A retrospective study to determine the impact of medical- and lifestyle-based contraindications to a prescribed HAART regimen on clinical outcomes and adherence

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 5, 2006, Pages 429-439

  Lal, L S ^a   Grimes, R M ^b   Swint, J M ^b   Risser, J ^b  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adherence; Contraindications; Highly active antiretroviral therapy; Outcomes

Indexed keywords

ABACAVIR; ALPRAZOLAM; AMIODARONE; AMPRENAVIR; ANTIVIRUS AGENT; CAFERGOT; CARBAMAZEPINE; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; DELVIRDINE; DIDANOSINE; DIHYDROERGOTOXINE MESILATE; EFAVIRENZ; ERGOTAMINE; FAMOTIDINE; FORTAVASE; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MIDAZOLAM; NELFINAVIR; NEVIRAPINE; PHENYTOIN; PIROXICAM; PROPAFENONE; RANITIDINE; RIFABUTIN; RIFAMPICIN; RITONAVIR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN; ZALCITABINE; ZIDOVUDINE;

ADULT; ANAMNESIS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG CONTRAINDICATION; FEMALE; HEART ARRHYTHMIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIGRAINE; OUTCOME ASSESSMENT; PAIN; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; SEIZURE; STOMACH DISEASE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEALTH STATUS; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 33748376887     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00755.x     Document Type: Review

References (13)

1. Centers for Disease Control and Prevention (2004) HIV/AIDS Surveillance Report, 2003, Vol. 15. Atlanta: US Department of Health and Human Services, Center for Disease Control and Prevention, Found at http://www.cdc.gov/hiv/ stats/2003SurveillanceReport.htm. Last accessed 16 January 2006.
2. Paletta FJ Jr, Delaney KM, Moorman AC et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine, 338, 853-860.
3. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV infected adolescents and adults. Adherence to potent antiretroviral therapy, 29 October 2004. Found at http://aidsinfo.nih.gov/guidelines. Last accessed 16 January 2006.
4. Paterson DL, Swindells S, Mohr J et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
5. Grimes R, Easling I, Ray S et al. (2000) Non-adherence to protease inhibitors in 758 patients from 3 separate cohorts of HIV infected patients in Houston, Texas, USA. [Abstract ThPeB4983] XIIIth International AIDS Conference, Durban, South Africa.
6. Wood E, Montaner JSG, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg R (2003) Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Canadian Medical Association Journal, 169, 656-661.
7. Montaner JSG, Reiss P, Cooper D, Vella S, Harris M, Conway B et al. (1998) A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. The Journal of the American Medical Association, 279, 930-937.
8. Mannheimer S, Friedland G, Matts J, Child C, Chesney M (2002) The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus infected persons in clinical trials. Clinical Infectious Diseases, 33, 466.
9. Cheever LW Adherence to HIV therapies. In: Anderson JR, ed. A guide to the clinical care of women with HIV. Found at http://hab.hrsa.gov/publications. htm.
10. Chesney M (2003) Adherence to HAART regimens. AIDS Patient Care and STDS, 17, 169-176.
11. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents (7 April 2002). Found at http://www.aidsinfo.nih.gov/guidelines. Last accessed 16 January 2006.
12. Grimes RM, Lal L, Lewis ST (2002) Frequency of medical history items, drug interactions, and lifestyle characteristics that may interfere with antiretroviral medications. HIV Clinical Trials, 3, 161-167.
13. Sloane PD, Zimmerman S, Brown LC, Ives TJ, Walsh JF (2002) Inappropriate medication prescribing in residential care/assisted living facilities. Journal of the American Geriatrics Society, 50, 1001-1011.